Efficacy and Safety of Sirolimus With or Without Cyclosporin A in Chinese Patients With Aplastic Anemia Refractory/Intolerant to Cyclosporin A

NCT06802055 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Aplastic Anaemia

Interventions

DRUG: Sirolimus (Rapamune®)
DRUG: Cyclosporin A (CsA)

Sponsor

Peking Union Medical College Hospital